SCHEMBL10180353

SCHEMBL10180353

CCS(=O)(=O)c1ccc(CC(C)C)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSIP1 O75475 2/20 0.59
ALDH1A1 P00352 3/20 0.58
RORC P51449 2/20 0.51
GAA P10253 1/20 0.50
KDM4E B2RXH2 3/20 0.46
LMNA P02545 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MEN1 O00255 1/20 0.46
HPGD P15428 1/20 0.46
KMT2A Q03164 1/20 0.46
POLB P06746 1/20 0.44
PTGS1 P23219 3/20 0.44
PTGS2 P35354 3/20 0.44
CYP2C9 P11712 2/20 0.44
AKR1C3 P42330 2/20 0.44
CXCR1 P25024 2/20 0.44
CXCR2 P25025 2/20 0.44
ALB P02768 1/20 0.44
ESR1 P03372 1/20 0.44
ALOX5 P09917 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17688569 0.84 PSIP1 (0.55) PSIP1ALDH1A1RORCGAA
SCHEMBL17695908 0.84 PSIP1 (0.55) PSIP1ALDH1A1RORCGAA
SCHEMBL21064584 0.83 ALDH1A1 (0.61) ALDH1A1GAAKDM4ELMNASMN1; SMN2
SCHEMBL7035999 0.81 ALDH1A1 (0.51) ALDH1A1RORCKDM4ELMNASMN1; SMN2
SCHEMBL7033096 0.81 CA2 (0.55) ALDH1A1KDM4ELMNASMN1; SMN2MEN1
SCHEMBL10180190 0.81 ALDH1A1 (0.51) ALDH1A1KDM4ELMNASMN1; SMN2MEN1
SCHEMBL2662553 0.81 ALDH1A1 (0.59) ALDH1A1KDM4ELMNASMN1; SMN2MEN1
SCHEMBL10180663 0.80 TSHR (0.56) ALDH1A1RORCKDM4ETSHR
SCHEMBL10181221 0.80 ALDH1A1 (0.50) ALDH1A1KDM4ELMNASMN1; SMN2MEN1
SCHEMBL3092073 0.79 CA2 (0.61) ALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3578562-B1 L-VALINATE AMIDE BENZOXABOROLE DERIVATIVES FOR THE TREATMENT OF PARASITIC DISEASES ANACOR PHARMACEUTICALS INC (US) 2021-06-23 EP disclosed
WO-2020186632-A1 BENZIDINE COMPOUND AND APPLICATION THEREOF 中国科学院广州生物医药与健康研究院 2020-09-24 WO disclosed
US-20130244122-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY EMPLOYING THE SAME ONUKI MASAMICHI (JP) 2013-09-19 US disclosed
US-20120219866-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2012-08-30 US disclosed
EP-2475041-A1 NON-AQUEOUS ELECTROLYTIC SOLUTION, AND NON-AQUEOUS ELECTROLYTE BATTERY COMPRISING SAME Mitsubishi Chemical Corporation (JP) 2012-07-11 EP disclosed